Clinical Trials
217 trialsMulticenter Prospective Study on MRI AI Model for Midline Glioma Subtyping and Prognosis:
Xiangya Hospital of Central South University
Multimodal Machine Learning Characterization of Solid Tumors
Massachusetts General Hospital
CSF-IMR
Medical University of Warsaw
Cognitive Changes of IDH-mutant and IDH-wildtype Glioma Patients After Chemoradiotherapy With Radiation Dose to the Resting State Networks
Washington University School of Medicine
BRAIN MATRIX
University of Birmingham
ResPGlioma
Universita degli Studi di Genova
Adaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade Glioma
Columbia University
LGG PRO's
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
APT-HGG
IRCCS Ospedale San Raffaele
A Pilot Study Using 18F-DOPA PET-guided Radiotherapy in Gliomas
Mayo Clinic
Targeted Pediatric High-Grade Glioma Therapy
Nationwide Children's Hospital
UFGAG
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Clinical, patHOlogical and Imaging Project of nEuro-oncology (HOPE)
Beijing Tiantan Hospital
m-ctDNA
University Health Network, Toronto
SC-Het-GM-CCS
The Children's Hospital of Zhejiang University School of Medicine
Serial Advanced Magnetic Resonance Imaging Scan for Guidance of Personalized Adaptive Radiotherapy for High Grade Glioma
M.D. Anderson Cancer Center
Improve TMZ
University College Cork
GLIOTARG
Blokhin's Russian Cancer Research Center
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
M.D. Anderson Cancer Center
NEMO
Tata Memorial Centre
Construction and Application of an IDH Mutation-Targeted PET/MRI Imaging Framework for Precision Diagnosis of Gliomas
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
C-SMART
Virginia Commonwealth University
Mapping of Electrical Properties in the Brain
Mayo Clinic
Amino Acid Transporter System PET/CT Imaging in AATS-Related Diseases
Tianjin Medical University
HiLoGlio
Maastricht Radiation Oncology
IMMUNO-IMAGING
Istituto Oncologico Veneto IRCCS
Location-Molecular Integrated Outcomes in 450 Cerebellar Glioma Microsurgical Cases
West China Hospital
fMRI Reveal Functional Preservation in Glioma Peritumoral Edema
West China Hospital
Advanced Development of Desorption Electrospray Ionization Mass Spectrometry for Intraoperative Molecular Diagnosis of Brain Cancer Using Pathology Biopsies
Mayo Clinic
FET-TREAT
Sunnybrook Health Sciences Centre
FESS
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
neGLIO
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Prospective Real-World Study of Pathology AI for Glioma Molecular Prediction
Nanfang Hospital, Southern Medical University
Developing a New Metabolic Imaging Approach (aMRI) for Evaluating Neurological Disease in Patients With Gliomas
OHSU Knight Cancer Institute
Study of Stored Tumor Samples in Young Patients With Brain Tumors
St. Jude Children's Research Hospital
AI-assisted Diagnosis of Malignant Brain Tumors
Second Affiliated Hospital, School of Medicine, Zhejiang University
PROGLIO
Centre Jean Perrin
Assessing Brain Metabolism Using MRS With Deuterated Glucose
University of California, San Francisco
ReGIT
Indiana University
APPEAR
LMU Klinikum
Multi-Dimensional MRI Spatial Heterogeneity Analysis for Predicting Key Genes and Prognosis of High-Grade Gliomas: A Multi-Center Study
RenJi Hospital
Radiolabeled TSPO Targeted Molecular Probe in Glioma
Nanjing First Hospital, Nanjing Medical University
VERONICA
Huashan Hospital
GUAVA
Royal North Shore Hospital
ALBATROSS
Universitat Politècnica de València
BIOhabitats
Universitat Politècnica de València
Glioma Developmental and HyperActive Ras Tumor (DHART) Board
Memorial Sloan Kettering Cancer Center
TEP-IDH
Central Hospital, Nancy, France
RADDOPAG-2
Central Hospital, Nancy, France
GRETeL: Tumor Response to Standard Radiotherapy and TMZ Patients With GBM
Duke University